exhibit 10. 41 policy of endo health solutions inc. relating to insider trading in company securities and confidentiality of information to : all personnel from : rajiv de silva, president & chief executive officer the board of directors has adopted the following policy which applies to all personnel ( including directors and officers ) of endo health solutions inc. and its subsidiaries ( collectively called the “ company ” ) arising from our legal and ethical responsibilities as a public company. this policy supersedes the policy adopted in november 2011 in its entirety. federal and state securities laws prohibit the purchase or sale of a company's securities by anyone who is aware of material information about that company that is not generally known or available to the public. these laws also prohibit anyone who is aware of material nonpublic information from disclosing this information to others who may trade. companies and their controlling persons may also be subject to liability if they fail to take reasonable steps to prevent insider trading by company personnel. 1. prohibition against trading on undisclosed material information : you are prohibited from engaging in any transaction in the company's securities while aware of material non - public information about the company. it makes no difference whether or not you relied upon or used material non - public information in deciding to trade - if you are aware of material non - public information about the company, the prohibition applies. this prohibition covers virtually all transactions in the company's securities, including purchases, sales, pledges, hedges, loans and gifts of the company's securities, as well as other direct or indirect transfers of the company's securities. this prohibition extends to trades of the company's securities in which you have any “ beneficial ” or other interest, or over which you exercise investment control, including : • transactions in the company's securities held in joint accounts or accounts of persons or entities controlled directly or indirectly by you ; • • transactions in the company's securities held in joint accounts or accounts of persons or entities controlled directly or indirectly by you ; transactions in the company's securities held in joint accounts or accounts of persons or entities controlled directly or indirectly by you ; • transactions in the company's securities for which you act as trustee, executor or custodian ; and • • transactions in the company's securities for which you act as trustee, executor or custodian ; and transactions in the company's securities for which you act as trustee, executor or